Bristol-Myers Squibb elects Gerald Storch to board of directors

pharmafile | January 26, 2012 | Appointment | Business Services, Manufacturing and Production, Research and Development, Sales and Marketing BMS, Gerald Storch 

Bristol-Myers Squibb has announced that its board has elected Gerald Storch to serve as a member of the audit committee, and the compensation and management development committee on the board of directors.

Storch, 55, is currently the chairman and chief executive of Toys ‘R’ Us, the world’s leading dedicated toy products retailer, a position he has held since 2006. From 1993 to 2005, he was employed by Target Corporation where he served in roles of increasing responsibility, including as vice chairman from January 2001 until his departure in October 2005.

Prior to joining Target, Storch was a partner at McKinsey & Company, specialising in retail and financial services.

“We are thrilled to have a person of Jerry’s caliber, an industry leader with an excellent track record of success in branding and positioning a global franchise for growth, on our board of directors,” said Lamberto Andreotti, chief executive, Bristol-Myers Squibb.

Advertisement

James Cornelius, chairman of Bristol-Myers Squibb, added, “Jerry’s broad business and financial experience, focus on innovation and tremendous integrity make him an ideal member of our board of directors. I look forward to his contributions.”

Related Content

Elekta and BMS partner for digital treatment for melanoma

Elekta and Bristol Myers Squibb have announced a pilot collaboration in which the companies plan …

BMS acquires Mirati Therapeutics for $4.8bn

Bristol Myers Squibb (BMS) and Mirati Therapeutics have announced that they have entered into a …

BMS shares new research and development  plans at the company’s R&D day

Bristol Myers Squibb (BMS) recently held a Research and Development (R&D) Day in New York, …

The Gateway to Local Adoption Series

Latest content